• New Research Data Network Aims to Advance Discovery of Huntington’s Treatment
  • Wave Life Sciences to Start Trials of Two Therapies That Target Huntington’s Mutations
  • People with Chorea Can Switch from Xenazine To Austedo Safely, Phase 3 Clinical Trial Shows
  • Metabolic Changes in Certain Brain Regions May Be Associated with Huntington’s Motor Symptoms
  • MSH3 Gene Mutations May Be Involved in Huntington’s Disease Progression, Study Finds
  • Mitoconix Bio Obtains $20 Million To Continue Developing Huntington’s Therapy MTC-1203
  • Ionis Completes Patient Enrollment in Phase 1/2a Trial of Ionis-HTTRx for Huntington’s Disease
  • Researchers Identify Variant in MSH3 Gene Related to Huntington’s Progression
  • Inhibiting Enzyme Slows Huntington’s Progression in Mice and Lengthens Their Lives, Study Reports
  • Low Pyk2 Protein Levels May Contribute to Memory Deficits in Huntington’s Disease, Study Shows
  • Researchers Propose NfL as New Blood Marker of Huntington’s Disease Onset, Progression
  • Cell Transport ‘Traffic Jam’ Caused by Mutated Protein, Researchers Discover